Meet the coordinator running the COVID-19 vaccine trial.
Yvonne De Los Reyes is in charge of the study at Quality of Life Medical & Research Centers.
Meet the coordinator running the COVID-19 vaccine trial.
Yvonne De Los Reyes is in charge of the study at Quality of Life Medical & Research Centers.
SPEED" -- AND THE CLINICCONDUCTING MODERNA'S COVID-19VACCINE TRAIL IN TUCSON -- ISNOW (ACCELERATING THE NUMBEROF PATIENTS IT'S ENROLLING --IN THIS GROUND BREAKING STUDY.TRT= 1:58"THIS VACCINE IS SUPPOSE TOKEEP PEOPLE FROM GETTINGCOVID.
THAT'S THE BOTTOM LINE.THE SCIENTIFIC BACKGROUND OFTHE VACCINE COMPONENTS ISPRETTY AMAZING." AS CLINICALRESEARCH COORDINATOR OFMODERNA'S COVID-19 VACCINETRIAL IN TUCSON -- YVONNE DELOS REYES IS AT THE HEART OFWHAT SHE CALLS THE MOSTIMPORTANT STUDY OF HER 15 YEARCAREER.
"RIGHT NOW IT'S GOINGGREAT." IN THE PAST TWO WEEKS-- SHE'S SETUP THE VACCINETRIAL AT QUALITY OF LIFEMEDICAL & RESEARCH CENTERS ONTHE EAST SIDE.
IT'S A HUGEUNDERTAKING.
YVONNE IS INCHARGE OF RECRUITINGPARTICIPANTS, COORDINATINGSTAFF, LABS TESTS, COLLECTINGTHE DATA, PLUS LOTS OFPAPERWORK TO DOCUMENT EACHPATIENT.
"AND IT'S GOT TO BEPRECISE, YES." QUALITY OF LIFECONTINUES TO ASK FORVOLUNTEERS -- ESPECIALLYLATINOS AND NATIVE AMERICANS-- HIT HARD BY THECORONAVIRUS.
MORE THAN THREETHOUSAND PEOPLE HAVE ALREADYVOLUNTEERED.
YVONNE SAYS IFYOU HAVEN'T BEEN CONTACTED --HAVE PATIENCE.
"WE'RE GOING TOEVENTUALLY GET TO THEM.
BUT WEALSO WANT TO MAKE SURE THEINTEGRITY OF THE STUDY ISBEING CONDUCTED PROPERLY."NATIONAL NEWS REPORTS THISWEEK SAY ENROLLINGPARTICIPANTS IN MODERNA'STRIAL -- AT THE NEARLY 90CLINICS ACROSS THE COUNTRY --HAS BEEN SLOWER THAN EXPECTED.BUT QUALITY OF LIFE ALREADYHAS MORE THAN 200 PEOPLEENROLLED -- INCLUDING MYSELF-- WITH AN ADDITIONAL 25PARTICIPANTS ADDED EACH DAY.THEY'LL SOON PASS MODERNA'SGOAL OF 300 PARTICIPANTSSCREENED AND RANDOMIZED INTOTHE TUCSON PORTION OF THECLINIC TRIAL.
BUT DR. JACKMCGETTIGAN -- THE OWNER OFQUALITY OF LIFE CLINICS --WANTS A THOUSAND PARTICIPANTS.A GOAL SHARED BY YVONNE."THAT'S THE OVERALL GOAL.
IT'SA LOT OF PATIENTS, A LOT OFWORK, BUT AT THE END OF THEDAY IT'LL BE WORTH IT."YVONNE SAYS -- LIKE ME --PARTICIPANTS ARE REPORTINGVERY LITTLE IN THE WAY OFREACTIONS TO THE FIRST DOSE OFTHE VACCINE.
SHE ALSO SAYS TWOMORE COVID VACCINE TRIALS AREABOUT TO BEGIN NATIONWIDE --AND Q-L-M-C IS HOPING TO RUNTHOSE TRIALS IN TUCSON.GOVERNOR DOUG DUCEY HELD A
The national institutes of health is overseeing the development of a vaccine against COVID-19.